CLINICAL TRIALS PROFILE FOR VANCOCIN HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for VANCOCIN HYDROCHLORIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00384527 ↗ | Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease | Terminated | Romark Laboratories L.C. | Phase 3 | 2006-12-01 | The primary objective of the study is to demonstrate non-inferiority of nitazoxanide compared to vancomycin in resolving symptoms of Clostridium difficile-associated disease (CDAD). |
NCT00428844 ↗ | Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci | Completed | Cubist Pharmaceuticals LLC | Phase 2 | 2007-06-26 | This is a research study designed to look at the efficacy and safety of daptomycin given at a dose of 6 mg/kg or 8 mg/kg in subjects being treated for prosthetic hip or knee infections caused by Staphylococci. These types of bacteria are among the most common types of bacteria causing infections of prosthetic joints. |
NCT00430937 ↗ | Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections | Terminated | Novartis Pharmaceuticals | Phase 3 | 2006-04-01 | This study evaluated the efficacy and safety of daptomycin compared to vancomycin or teicoplanin for the treatment of complicated skin and soft tissue infections |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VANCOCIN HYDROCHLORIDE
Condition Name
Clinical Trial Locations for VANCOCIN HYDROCHLORIDE
Trials by Country
Clinical Trial Progress for VANCOCIN HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for VANCOCIN HYDROCHLORIDE
Sponsor Name